Scholarlink

Background <p>Gouty arthritis (GA) is a common and painful inflammatory joint disease. Acetylshikonin (Askn), a major bioactive compound extracted from the traditional Chinese medicine <i>Arnebia euchroma</i>, has an unknown therapeutic potential and mechanism of action against GA. This study aimed to investigate the effects and underlying mechanisms of Askn in a mouse model of GA.</p> Methods <p>A GA model was established in 6- to 8-week-old male mice by injecting a 3% monosodium urate (MSU) crystal suspension into the hind paw metatarsophalangeal joint. The mice were randomly divided into three groups: the healthy control group, the GA model group, and the Askn-treated group (30&#xa0;mg/kg, i.p.). Each group consisted of <i>n</i> = 10 mice. The primary endpoint was the degree of paw swelling, which was assessed by a Vernier calliper. Secondary assessments included liver/kidney toxicity (H&amp;E staining and ultrasound), inflammatory factor expression (qRT‒PCR and immunofluorescence), and lymphatic drainage (ICG‒NIR imaging).</p> Results <p>Paw swelling was significantly lower in Askn-treated mice than in the GA model group. Askn treatment did not induce hepatotoxicity or nephrotoxicity. A significant improvement in the inflammatory pathological condition of the synovial tissues and surrounding soft tissues at the metatarsophalangeal joint was observed in Askn-treated mice. The mRNA expression of IL-1β, TNF-α, IL-6, and iNOS markedly decreased following Askn treatment. Furthermore, Askn significantly enhanced lymphatic drainage, as indicated by ICG signal intensity, and modulated the SIRT1/NLRP3 pathway.</p> Conclusion <p>Askn alleviates GA symptoms by enhancing lymphatic drainage and upregulating SIRT1 expression, which subsequently inhibits NLRP3-mediated inflammation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Acetylshikonin alleviates gouty arthritis by increasing sirtuin1 expression and promoting lymphatic drainage

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月6日

查看全文
  • Changgui Wu,
  • Jun Yan,
  • Shaohua Chen,
  • Xiaoying Chu,
  • Xiaobing Xi

摘要

Background

Gouty arthritis (GA) is a common and painful inflammatory joint disease. Acetylshikonin (Askn), a major bioactive compound extracted from the traditional Chinese medicine Arnebia euchroma, has an unknown therapeutic potential and mechanism of action against GA. This study aimed to investigate the effects and underlying mechanisms of Askn in a mouse model of GA.

Methods

A GA model was established in 6- to 8-week-old male mice by injecting a 3% monosodium urate (MSU) crystal suspension into the hind paw metatarsophalangeal joint. The mice were randomly divided into three groups: the healthy control group, the GA model group, and the Askn-treated group (30 mg/kg, i.p.). Each group consisted of n = 10 mice. The primary endpoint was the degree of paw swelling, which was assessed by a Vernier calliper. Secondary assessments included liver/kidney toxicity (H&E staining and ultrasound), inflammatory factor expression (qRT‒PCR and immunofluorescence), and lymphatic drainage (ICG‒NIR imaging).

Results

Paw swelling was significantly lower in Askn-treated mice than in the GA model group. Askn treatment did not induce hepatotoxicity or nephrotoxicity. A significant improvement in the inflammatory pathological condition of the synovial tissues and surrounding soft tissues at the metatarsophalangeal joint was observed in Askn-treated mice. The mRNA expression of IL-1β, TNF-α, IL-6, and iNOS markedly decreased following Askn treatment. Furthermore, Askn significantly enhanced lymphatic drainage, as indicated by ICG signal intensity, and modulated the SIRT1/NLRP3 pathway.

Conclusion

Askn alleviates GA symptoms by enhancing lymphatic drainage and upregulating SIRT1 expression, which subsequently inhibits NLRP3-mediated inflammation.